(Press-News.org) The public, legislators, and media often group per- and polyfluoroalkyl substances, known as PFAS or “forever chemicals,” which are found globally in countless products, into a single category. While certain PFAS are harmful for human and public health, new articles in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, emphasize that fluoropolymers, a specific class of PFAS, are not considered environmental contaminants and are indispensable for use in medical devices. Experts call for a balanced approach to protect both the environment and availability of essential medical technologies.
PFAS are found in a constellation of products across all sectors of commerce and all parts of the globe. These industries include textiles, aerospace, communications, electronics, pharmaceuticals, energy, and healthcare.
In their article “The role of per- and polyfluoroalkyl substances in medical devices and delivery systems: Why the electrophysiologist should care,” Heart Rhythm Society member and clinician from the Minneapolis Heart Institute Pierce J. Vatterott, MD, and biomaterial scientists Paul D. Drumheller, PhD, Nadine Ding, PhD, and Joyce Wong, PhD, explain, “Due to their high chemical stability, PFAS are persistent in the environment and certain PFAS have been linked to water contamination, environmental effects, and human disease. Two noteworthy substances are the water-soluble, small-molecule compounds perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). These two compounds are considered environmental contaminants by the US Environmental Protection Agency (EPA).”
PFAS encompass over 12,000 compounds besides PFOA and PFOS and fall into distinct classes that have vastly different chemical, biological, and toxicological properties. One specific class of PFAS – fluoropolymers – are essential to human and public health, especially to cardiac electrophysiology. According to the US Food and Drug Administration, approximately 250,000 approved medical devices contain fluoropolymers. These fluoropolymers undergo extensive biocompatibility and pre-clinical testing and have not been linked to health issues associated with their long-term use. Fluoropolymers are significantly larger than water-soluble PFAS and are not considered environmental contaminants by the EPA.
Fluoropolymers are critical in all phases of medical device use (e.g., cardiac implantable electronic devices, ablation catheters and sheaths), including their manufacturing process, performance, and delivery within the human body.
Noted expert Roger Carrillo, MD, MBA, FHRS, Chief of Surgical Electrophysiology at Palmetto General Hospital, Miami, emphasizes: “Fluoropolymers play a crucial role in thousands of modern medical devices. Their unique properties have enabled the miniaturization of valves, created slippery surfaces for catheters, and provided the flexibility and electrical insulation essential for components of leads and cardiac pacemakers. Unlike smaller PFAS molecules linked to health concerns and water contamination, these large polymers have not been associated with such issues. It is imperative that clinicians understand the important differences within this diverse class of compounds. Dr. Vatterott et al.’s contribution in Heart Rhythm provides a concise, detailed, and informative insight into this topic.”
The authors point out, "At present, no other class of materials exists with fluoropolymers’ unique combined properties including lubricity, biostability, temperature tolerance, strength, flexibility, and electrical insulation. For over 50 years, they have been safely used in medical devices such as brain shunts, cardiac valves, catheters, vascular grafts, pacemakers, and defibrillator systems. Fluoropolymers enable minimally invasive procedures, improve long-term device function, reliability, and allow significant advancements including device miniaturization."
In the accompanying article “PFAS regulations and the potential impacts on patient care,” the authors highlight key proposed and enacted bans and restrictions, particularly in the US at the federal and state levels, Canada, and the European Union. “Many legislations seek to regulate these over 12,000 distinct chemicals as a single class, motivated by the known risks of specific water-soluble, small-molecule compounds, i.e., they do not distinguish between toxic water-soluble small-molecule PFAS and medical fluoropolymers. These efforts are threatening the availability of fluoropolymers even in cases where medical device exclusions are allowed,” notes lead author Paul D. Drumheller, PhD, American Institute for Medical and Biological Engineering, Washington, DC.
The authors of the accompanying editorial "What every electrophysiologist should know and worry about," Kenneth A. Ellenbogen, MD, FHRS, Medical College of Virginia / VCU School of Medicine, Richmond, and Charles D. Swerdlow MD, FHRS, Smidth Heart Institute at Cedars Sinai Medical Center, Los Angeles, say, “Because small-molecule PFAS are toxic, PFAS are increasingly being regulated worldwide; and much legislation does not distinguish between small, toxic molecules and medical fluoropolymers. PFAS manufacturers are not waiting for these regulations to take effect. They are exiting the medical fluoropolymer market, threatening the supply chain for all medical products that use fluoropolymers. Thus, these proposed and enacted regulations have important implications for clinical electrophysiologists worldwide. The articles in Heart Rhythm help us better understand the complex issues surrounding PFAS and medical fluoropolymers.”
Dr. Vatterott concludes, “Loss of access to fluoropolymers will have profound negative effects for our patients and on the practice of medicine, especially cardiac electrophysiology. It is critical to find a path that protects our environment but ensures the availability of fluoropolymers that are essential in medical devices, minimally invasive procedures, and drives ongoing innovation in medical technology.”
END
Not all "forever chemicals" are equal: Experts call for nuanced PFAS policy to protect human and public health and the environment
Articles in Heart Rhythm highlight the urgent need to distinguish between harmful PFAS and essential fluoropolymers used in medical technology
2025-07-14
ELSE PRESS RELEASES FROM THIS DATE:
‘Hope isn’t enough – we need action when it comes to climate change’, an earth scientist’s guide for the future
2025-07-14
Climate change is coming… but what on Earth can we do about it? Scientist Dr. Kimberley Miner has written a guide to riding out the oncoming almighty storm.
Miner is an Earth scientist whose research includes studying the changing Poles of Earth, the Arctic’s melting permafrost, forever chemicals and plastic pollution. Her new book Considering Climate Change provides practical guidance for young people concerned about the future.
She poses questions like how to deal with eco-anxiety and climate-grief, how to prepare financially, ...
Obesity rates in Canada increased after start of COVID-19 pandemic
2025-07-14
Did the COVID-19 pandemic affect obesity rates in Canada? A new study in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241421 found obesity rates based on body mass index (BMI) increased faster in the 4 years after the start of the pandemic than in the previous 11 years, especially in younger adults.
“Compared with the average increase during the 11 years before the pandemic, the prevalence of obesity [as measured by BMI] increased at a greater rate during the 4 years after the onset of the COVID-19 pandemic (2020–2023), suggesting that the COVID-19 pandemic and associated public health restrictions ...
Supporting autistic patients in health care
2025-07-14
Caring for autistic patients requires a unique approach, and a Five ways to support… article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250152 aims to provide tips on caring for these patients.
Suggestions include offering online bookings and virtual consultations, adapting health care delivery and environments to reduce sensory overstimulation, tailoring communications for individual patients, ensuring clarity and predictability in health care encounters, ...
New study finds sharp increase in nicotine pouch ingestions among young children
2025-07-14
(COLUMBUS, Ohio) – A new study reveals that ingestions of nicotine pouches by young children have surged in recent years. Researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital and the Central Ohio Poison Center analyzed calls to U.S. poison centers and found an alarming 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023. Nicotine pouches were also more ...
LIGO-Virgo-KAGRA detect most massive black hole merger to date
2025-07-13
The LIGO-Virgo-KAGRA (LVK) Collaboration has detected the merger of the most massive black holes ever observed with gravitational waves using the US National Science Foundation (NSF)-funded LIGO observatories. The powerful merger produced a final black hole approximately 225 times the mass of our Sun. The signal, designated GW231123, was detected during the fourth observing run of the LVK network on November 23, 2023.
LIGO, the Laser Interferometer Gravitational-wave Observatory, made history in 2015 when it made the first-ever direct detection of gravitational waves, ripples in space-time. In that case, the waves emanated from a black ...
Lonely adults may have a higher risk of diabetes
2025-07-13
SAN FRANCISCO—Socially isolated older adults are at increased risk of developing diabetes and high blood sugar, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
“Social isolation and loneliness have been increasingly recognized as important health risk factors after the COVID-19 pandemic. Our findings underscore the importance for clinicians to recognize social isolation as a critical social determinant of health when ...
Intermittent energy restriction may improve outcomes in people with obesity and type 2 diabetes
2025-07-13
SAN FRANCISCO—Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
“This study is the first to compare the effects of three different dietary interventions intermittent energy restriction (IER), time-restricted eating (TRE) and continuous energy restriction (CER) in managing type 2 diabetes with obesity,” said Haohao Zhang, Ph.D., chief physician ...
Grandfather’s environmental chemical exposures may influence when girls get first period
2025-07-13
SAN FRANCISCO—A grandfather’s exposure to endocrine-disrupting chemicals may impact the age when his granddaughter starts her first period, according to preliminary data being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
“Girls are starting puberty earlier than ever before, which can raise their risk for health problems later in life,” said lead researcher Xin Hu, PhD, of Emory University’s Rollins School of Public Health in Atlanta, Ga. “We wanted to explore why this might be happening by looking at how environmental exposures from grandparents can influence when girls ...
Early-life exposure to endocrine-disrupting chemicals may fuel food preferences
2025-07-13
SAN FRANCISCO—Exposure to endocrine-disrupting chemicals in early life, including during gestation and infancy, results in a higher preference for sugary and fatty foods later in life, according to an animal study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
Endocrine-disrupting chemicals are substances in the environment (air, soil or water supply), food sources, personal care products and manufactured products that interfere with the normal function ...
Age at woman’s first period can offer clues about long-term health risks
2025-07-13
SAN FRANCISCO—The age at which a woman has her first period can offer valuable clues about her long-term risk for conditions like obesity, diabetes, heart disease and reproductive health issues, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
The Brazilian study found that both early and late menarche—the age when women first get their period—are linked to different health risks. Women who had their first period before age 10 were more ...
LAST 30 PRESS RELEASES:
So what do the world’s coastlines look like in 2025?
High-purity green hydrogen with very low tar from biomass, with chemical looping gasification
Not all "forever chemicals" are equal: Experts call for nuanced PFAS policy to protect human and public health and the environment
‘Hope isn’t enough – we need action when it comes to climate change’, an earth scientist’s guide for the future
Obesity rates in Canada increased after start of COVID-19 pandemic
Supporting autistic patients in health care
New study finds sharp increase in nicotine pouch ingestions among young children
LIGO-Virgo-KAGRA detect most massive black hole merger to date
Lonely adults may have a higher risk of diabetes
Intermittent energy restriction may improve outcomes in people with obesity and type 2 diabetes
Grandfather’s environmental chemical exposures may influence when girls get first period
Early-life exposure to endocrine-disrupting chemicals may fuel food preferences
Age at woman’s first period can offer clues about long-term health risks
AI-powered application enables clinicians to diagnose endocrine cancers faster and more accurately
Obesity-associated cancers tripled nationwide over past two decades
Consuming certain sweeteners may increase risk of early puberty
Experts suggest screening women with diabetes for intent to conceive at every doctor visit
Osteoporosis treatment benefits people older than 80
Consuming more protein may protect patients taking anti-obesity drug from muscle loss
Thyroid treatment may improve gut health in people with hypothyroidism
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
High blood sugar may have a negative impact on men’s sexual health
Emotional health of parents tied to well-being of children with growth hormone deficiency
Oxytocin may reduce mood changes in women with disrupted sleep
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
[Press-News.org] Not all "forever chemicals" are equal: Experts call for nuanced PFAS policy to protect human and public health and the environmentArticles in Heart Rhythm highlight the urgent need to distinguish between harmful PFAS and essential fluoropolymers used in medical technology